Bayport Management Ltd Unaudited Financial Statement 31 March 2025

News Room

Less than 1 min.Read

By Investing Today

May 19, 2025

Facebook

Twitter

Bayport Management Ltd Unaudited Financial Statement 31 March 2025

Attachments

Group Quarterly Report_March 2025
Group Quarterly Report_March 2025

Hot this week

News Room

SEALSQ Announces Results of Its 2025 Annual General Meeting (“AGM”) of Shareholders Held on May 19, 2025

May 19, 2025 0

Geneva, Switzerland, May 19, 2025 (GLOBE NEWSWIRE)...

News Room

Voltalia announces the appointment of two new Board members, including one independent

May 19, 2025 0

Voltalia announces the appointment of two new Board members,...

News Room

IBA – ACQUISITION OF OWN SHARES

May 19, 2025 0

Immediate Release – May 19th,...

News Room

Aramis Group – Governance changes at Aramis Group

May 19, 2025 0

PRESS RELEASE Arcueil, May 19, 2025 Governance...

News Room

Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study

May 19, 2025 0

- For each 5-mg/dL increase in serum TTR level...

Topics

News Room

SEALSQ Announces Results of Its 2025 Annual General Meeting (“AGM”) of Shareholders Held on May 19, 2025

Geneva, Switzerland, May 19, 2025 (GLOBE NEWSWIRE)...

News Room

Voltalia announces the appointment of two new Board members, including one independent

Voltalia announces the appointment of two new Board members,...

News Room

IBA – ACQUISITION OF OWN SHARES

Immediate Release – May 19th,...

News Room

Aramis Group – Governance changes at Aramis Group

PRESS RELEASE Arcueil, May 19, 2025 Governance...

News Room

Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study

- For each 5-mg/dL increase in serum TTR level...

News Room

Spineway : Combined General Meeting of June 4, 2025 – Availability of preparatory documents

Press release Ecully, May 19,...

News Room

Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the American Thoracic Society International Conference

KT-621, a potent, selective, oral STAT6 degrader, demonstrated comparable...

News Room

Transaction in Own Shares

Transaction in Own Shares 19 May, 2025 ...

SEALSQ Announces Results of Its 2025 Annual General Meeting (“AGM”) of Shareholders Held on May 19, 2025

News Room May 19, 2025

Voltalia announces the appointment of two new Board members, including one independent

News Room May 19, 2025

IBA – ACQUISITION OF OWN SHARES

News Room May 19, 2025

Aramis Group – Governance changes at Aramis Group

News Room May 19, 2025

Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study

News Room May 19, 2025

Popular Categories

News RoomFeatured CompaniesVideos

Alm. Brand A/S – Weekly report on share buybacks

Man Group PLC : Form 8.3 – LondonMetric Property plc

Bayport Management Ltd Unaudited Financial Statement 31 March 2025

SEALSQ Announces Results of Its 2025 Annual General Meeting (“AGM”) of Shareholders Held on May 19, 2025

Voltalia announces the appointment of two new Board members, including one independent

IBA – ACQUISITION OF OWN SHARES

Aramis Group – Governance changes at Aramis Group

Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study

Topics

SEALSQ Announces Results of Its 2025 Annual General Meeting (“AGM”) of Shareholders Held on May 19, 2025

Voltalia announces the appointment of two new Board members, including one independent

IBA – ACQUISITION OF OWN SHARES

Aramis Group – Governance changes at Aramis Group

Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study

Spineway : Combined General Meeting of June 4, 2025 – Availability of preparatory documents

Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the American Thoracic Society International Conference

Transaction in Own Shares

Related Articles

SEALSQ Announces Results of Its 2025 Annual General Meeting (“AGM”) of Shareholders Held on May 19, 2025

Voltalia announces the appointment of two new Board members, including one independent

IBA – ACQUISITION OF OWN SHARES

Aramis Group – Governance changes at Aramis Group

Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study

Company

Headlines

SEALSQ Announces Results of Its 2025 Annual General Meeting (“AGM”) of Shareholders Held on May 19, 2025

Voltalia announces the appointment of two new Board members, including one independent

IBA – ACQUISITION OF OWN SHARES

Aramis Group – Governance changes at Aramis Group

Newsletter